BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Juno’ And Celgene’s Investigational Drug JCAR017 Granted Breakthrough Therapy Designation From FDA And Priority Medicines Eligibility From EMAFor Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  December 20, 2016

   · 

  5 min read
• Bio NC

  RUBRACA (Rucaparib) Approved For The Treatment Of Advanced Ovarian Cancer, Available Immediately At Biologics

  December 20, 2016

   · 

  3 min read
• Business

  ChipCare Corporation Expands Scientific Team

  December 20, 2016

   · 

  3 min read
• Business

  Royal Philips Electronics N.V. And CHRISTUS Health Expand Relationship With Enhanced Population Health Management Capabilities

  December 20, 2016

   · 

  5 min read
• BioMidwest

  Avella Selected By Clovis Oncology To Distribute RUBRACA (Rucaparib)

  December 20, 2016

   · 

  2 min read
• Business

  Visioneering Technologies Announces Brian Atkinson As Territory Manager For The Dallas/Ft. Worth Market

  December 20, 2016

   · 

  1 min read
• Business

  Virginia Bio Welcomes New Members To Its Board Of Directors

  December 20, 2016

   · 

  6 min read
• Drug Development

  Repros Therapeutics Requests Meeting With FDA To Discuss Phase 3 Requirements For Proellex In The Treatment Of Endometriosis

  December 20, 2016

   · 

  2 min read
• BioCapital

  Sucampo Announces Proposed Convertible Senior Note Offering

  December 20, 2016

   · 

  4 min read
• BioForest

  National Human Genome Research Institute Release: New Study Identifies Which Physical Features Are Best Indicators Of Down Syndrome In Diverse Populations

  December 20, 2016

   · 

  4 min read